Pioglitazone revisited to illuminate contemporary vascular reparative therapy in the era of drug-eluting stents.
Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Toshiro
T
Shinke
D003331:Coronary Vessels; D003924:Diabetes Mellitus, Type 2; D003925:Diabetic Angiopathies; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D035683:MicroRNAs / Q000097:blood*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage*; D041623:Tomography, Optical Coherence
D007004:Hypoglycemic Agents; C543845:MIRN24 microRNA, human; D035683:MicroRNAs; D045162:Thiazolidinediones; D000077205:Pioglitazone